Pei-Yi Chu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 37

Top Venues

International journal of molecular sciences

Cancers

Biomedicines

Journal of personalized medicine

Show Chwan Memorial Hospital

National Taiwan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Show Chwan Memorial Hospital Dec 01 2014

Taiwan

Director :: Department of Pathology

Fu Jen Catholic University Sep 01 2013

Taiwan

Adjunct Assistant Professor :: School of Medicine, College of Medicine

National Health Research Institutes Jun 01 2009

Taiwan

Visiting staff :: National Institute of Cancer Research

St. Martin de Porres Hospital Apr 01 2011 - Nov 30 2014

Taiwan

Director :: Department of Pathology

Changhua Christian Hospital Nov 01 2006 - Mar 31 2011

Taiwan

Visiting Staff :: Department of Pathology

Education History

National Taiwan University Sep 01 2008 - Jan 31 2012

Taiwan

PHD :: College of Veterinary Medicine

Publications

Jung-Yu Kan, Shen-Liang Shih, Sheau-Fang Yang, Pei-Yi Chu, Fang-Ming Chen, Chung-Liang Li, Yi-Chia Wu, Yao-Tsung Yeh, Ming-Feng Hou, Chih-Po Chiang
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. International journal of molecular sciences 25 (2) (2024)
Jung-Yu Kan, Shen-Liang Shih, Sheau-Fang Yang, Pei-Yi Chu, Fang-Ming Chen, Chung-Liang Li, Yi-Chia Wu, Yao-Tsung Yeh, Ming-Feng Hou, Chih-Po Chiang
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. International journal of molecular sciences 25 (2) (2024)
Jung-Yu Kan, Shen-Liang Shih, Sheau-Fang Yang, Pei-Yi Chu, Fang-Ming Chen, Chung-Liang Li, Yi-Chia Wu, Yao-Tsung Yeh, Ming-Feng Hou, Chih-Po Chiang
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. International journal of molecular sciences 25 (2) (2024)
Po-Ming Chen, Chui-Nguk Wong, Chui-Na Wong, Pei-Yi Chu
Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Po-Ming Chen, Chui-Nguk Wong, Chui-Na Wong, Pei-Yi Chu
Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Po-Ming Chen, Chui-Nguk Wong, Chui-Na Wong, Pei-Yi Chu
Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Po-Ming Chen, Chui-Nguk Wong, Chui-Na Wong, Pei-Yi Chu
Actin-like Protein 6A Expression Correlates with Cancer Stem Cell-like Features and Poor Prognosis in Ovarian Cancer. International journal of molecular sciences 24 (3) (2023)
Pei-Yi Chu, Dev-Aur Chou, Po-Ming Chen, En-Pei Isabel Chiang
Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma. International journal of molecular sciences 24 (10) (2023)
Chun-Chi Chen, Pei-Yi Chu, Hung-Yu Lin
Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. International journal of molecular sciences 24 (10) (2023)
Hsing-Ju Wu, Pei-Yi Chu
Current and Developing Liquid Biopsy Techniques for Breast Cancer. Cancers 14 (9) (2022)
Ming-Hsien Hu, Pei-Yi Chu, Ssu-Meng Huang, Bo-Sin Shih, Chia-Ling Ko, Jeng-Shiung Jan, Wen-Cheng Chen
Injectability, Processability, Drug Loading, and Antibacterial Activity of Gentamicin-Impregnated Mesoporous Bioactive Glass Composite Calcium Phosphate Bone Cement In Vitro. Biomimetics (Basel, Switzerland) 7 (3) (2022)
Chun-Chi Chen, Pei-Yi Chu, Hung-Yu Lin
Multi-Omics Analysis Reveals Clinical Value and Possible Mechanisms of ATAD1 Down-Regulation in Human Prostate Adenocarcinoma. Life (Basel, Switzerland) 12 (11) (2022)
Yu-Hsuan Hung, Shih-Han Hsu, Ya-Chin Hou, Pei-Yi Chu, Yung-Yeh Su, Yan-Shen Shan, Wen-Chun Hung, Li-Tzong Chen
Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway. International journal of molecular sciences 23 (5) (2022)
Yung-Kai Lin, Hsing-Ju Wu, Nguyen Van Hieu, Pei-Yi Chu, Thi Vien Thao Do, Fiona Yan-Dong Yao, Thien Luan Phan, Congo Tak-Shing Ching
A New Biorecognition-Element-Free IDμE Sensor for the Identification and Quantification of E. coli . Biosensors 12 (8) (2022)
Hsing-Ju Wu, Pei-Yi Chu
Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer. International journal of molecular sciences 22 (2) (2021)
Wei-Chieh Huang, Hsiang-Cheng Chi, Shiao-Lin Tung, Po-Ming Chen, Ya-Chi Shih, Yi-Ching Huang, Pei-Yi Chu
Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 10 (10) (2021)
Pei-Yi Chu, Shih-Hsuan Chan
Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular Carcinoma. Cancers 13 (21) (2021)
Hsing-Ju Wu, Pei-Yi Chu
Epigenetic Regulation of Breast Cancer Stem Cells Contributing to Carcinogenesis and Therapeutic Implications. International journal of molecular sciences 22 (15) (2021)
Ya-Ling Yang, Ming-Chao Tsai, Yen-Hsiang Chang, Chen-Chen Wang, Pei-Yi Chu, Hung-Yu Lin, Ying-Hsien Huang
MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA. International journal of molecular sciences 22 (11) (2021)
Hung-Yu Lin, Hui-Wen Ho, Yen-Hsiang Chang, Chun-Jui Wei, Pei-Yi Chu
The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future. Cancers 13 (18) (2021)
Ya-Ling Yang, Yen-Hsiang Chang, Giou-Teng Yiang, Ying-Hsien Huang, Ming-Chao Tsai, Pei-Yi Chu, Hung-Yu Lin
New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics. Journal of personalized medicine 11 (3) (2021)
Giou-Teng Yiang, Yen-Dun Tony Tzeng, Yi-Han Chiu, Hung-Yu Lin, Ming-Feng Hou, Pei-Yi Chu
Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer. Cancers 13 (12) (2021)
Pei-Yi Chu, Hsing-Ju Wu, Shin-Mae Wang, Po-Ming Chen, Feng-Yao Tang, En-Pei Isabel Chiang
MAT2A Localization and Its Independently Prognostic Relevance in Breast Cancer Patients. International journal of molecular sciences 22 (10) (2021)
Giou-Teng Yiang, Li-Te Lin, Pei-Yi Chu, An-Jen Chiang, Hsiao-Wen Tsai, Yi-Han Chiu, Mei-Shu Huang, Zhi-Hong Wen, Kuan-Hao Tsui
Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer. Journal of personalized medicine 11 (4) (2021)
Chih-Jan Ko, Shih-Ling Gao, Tsu-Kung Lin, Pei-Yi Chu, Hung-Yu Lin
Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson's Disease. Biomedicines 9 (11) (2021)
Pei-Yi Chu, Yen-Dun Tony Tzeng, Yi-Han Chiu, Hung-Yu Lin, Chen-Hsin Kuo, Ming-Feng Hou, Giou-Teng Yiang
Multi-Omics Reveals the Immunological Role and Prognostic Potential of Mitochondrial Ubiquitin Ligase MARCH5 in Human Breast Cancer. Biomedicines 9 (10) (2021)
Hung-Yu Lin, Pei-Yi Chu
Advances in Understanding Mitochondrial MicroRNAs (mitomiRs) on the Pathogenesis of Triple-Negative Breast Cancer (TNBC). Oxidative medicine and cellular longevity 2021 (2021)
Kuan-Chung Hsiao, Pei-Yi Chu, Gee-Chen Chang, Ko-Jiunn Liu
Elevated Expression of Lumican in Lung Cancer Cells Promotes Bone Metastasis through an Autocrine Regulatory Mechanism. Cancers 12 (1) (2020)
Hung-Yu Lin, Giou-Teng Yiang, Ya-Ling Yang, Ying-Hsien Huang, Ya-Tze Hsiau, Pei-Yi Chu
Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer. International journal of molecular sciences 21 (24) (2020)
Yu-Chu Wang, Jau-Ling Huang, Ka-Wo Lee, Hsing-Han Lu, Yuan-Jen Lin, Long-Fong Chen, Chung-Sheng Wang, Yun-Chiao Cheng, Zih-Ting Zeng, Pei-Yi Chu, Chang-Shen Lin
Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53's DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption. Cancers 12 (8) (2020)
Pei-Yi Chu, Shin-Mae Wang, Po-Ming Chen, Feng-Yao Tang, En-Pei Isabel Chiang
Expression of MTDH and IL-10 Is an Independent Predictor of Worse Prognosis in ER-Negative or PR-Negative Breast Cancer Patients. Journal of clinical medicine 9 (10) (2020)
Shin-Mae Wang, Po-Ming Chen, Yu-Wen Sung, Wei-Chieh Huang, Hung-Sen Huang, Pei-Yi Chu
Effect of COL4A1 Expression on the Survival of Neoadjuvant Chemotherapy Breast Cancer Patients. Journal of oncology 2020 (2020)
Giou-Teng Yiang, Pei-Yi Chu, Giou-Teng Yiang, Meng-Yu Wu
The Molecular Mechanism of Epithelial-Mesenchymal Transition for Breast Carcinogenesis. Biomolecules 9 (9) (2019)
Jeffrey S Chang, Sung-Hsin Kuo, Pei-Yi Chu, Yan-Shen Shan, Chia-Rung Tsai, Hui-Jen Tsai, Li-Tzong Chen
The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A Nationwide Cancer Registry-Based Study in Taiwan. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (10) (2019)
Chih-Jan Ko, Giou-Teng Yiang, Meng-Yu Wu, Pei-Yi Chu
Overexpression of LGR-5 as a Predictor of Poor Outcome in Patients with Hepatocellular Carcinoma. International journal of environmental research and public health 16 (10) (2019)
Hsing-Ju Wu, Pei-Yi Chu
Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International journal of molecular sciences 20 (17) (2019)
Jing-Yi Chen, You-Syuan Lai, Pei-Yi Chu, Shih-Hsuan Chan, Lu-Hai Wang, Wen-Chun Hung
Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment. Cancers 11 (8) (2019)

Pei-Yi Chu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pei-Yi Chu